Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201310140 Principal Investigator: Amin, Manik
Title: Phase 2 Study of SPI-1620 in Combination with Docetaxel as a Second-Line Treatment for Patients with Advanced Biliary Cancer
Phase: II Disease Site: Other Digestive Organ
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to determine whether adding an investigational drug, SPI-1620, to standard treatment with docetaxel will help treat biliary cancer.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)